Hence, it was suggestive that mGluR5 enhancing drugs might improve sleep spindle losses, task-evoked gamma deficits, and specific sleep difficulties in addition to alleviating more notable symptoms of schizophrenia [22,56]. The gene discussed is GRM5; the disease is schizophrenia.